Related references
Note: Only part of the references are listed.SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
Ceri Alan Fielding et al.
ELIFE (2022)
Toll-Like Receptor 2-Tpl2-Dependent ERK Signaling Drives Inverse Interleukin 12 Regulation in Dendritic Cells and Macrophages
Sarah G. Groft et al.
INFECTION AND IMMUNITY (2021)
Opposing activities of IFITM proteins in SARS-CoV-2 infection
Guoli Shi et al.
EMBO JOURNAL (2021)
IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans
Dannielle Wellington et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2
Helena Winstone et al.
JOURNAL OF VIROLOGY (2021)
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
Edward L. Huttlin et al.
CELL (2021)
Optimal CD8+ T-cell memory formation following subcutaneous cytomegalovirus infection requires virus replication but not early dendritic cell responses
Sandra Dimonte et al.
IMMUNOLOGY (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
Caterina Prelli Bozzo et al.
NATURE COMMUNICATIONS (2021)
IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models
Jessica L. Forbester et al.
JOURNAL OF VIROLOGY (2020)
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019
Yonghong Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia
Leon Caly et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape
Philipp Hubel et al.
NATURE IMMUNOLOGY (2019)
IFITM3: How genetics influence influenza infection demographically
Dannielle Wellington et al.
BIOMEDICAL JOURNAL (2019)
Disruption of endocytosis through chemical inhibition of clathrin heavy chain function
Wim Dejonghe et al.
NATURE CHEMICAL BIOLOGY (2019)
IFITM3 protects the heart during influenza virus infection
Adam D. Kenney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
IFITM3 directly engages and shuttles incoming virus particles to lysosomes
Jennifer S. Spence et al.
NATURE CHEMICAL BIOLOGY (2019)
Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes
Krishna C. Suddala et al.
PLOS PATHOGENS (2019)
Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection
Shokouh Makvandi-Nejad et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
RTN4 Knockdown Dysregulates the AKT Pathway, Destabilizes the Cytoskeleton, and Enhances Paclitaxel-Induced Cytotoxicity in Cancers
Gopal P. Pathak et al.
MOLECULAR THERAPY (2018)
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
Patty Sachamitr et al.
FRONTIERS IN IMMUNOLOGY (2018)
IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3
Li-Qun Jiang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis
Maria A. Stacey et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans
E. Kaitlynn Allen et al.
NATURE MEDICINE (2017)
The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice
Alexa Patoine et al.
PLOS ONE (2017)
Dendritic cell migration in health and disease
Tim Worbs et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Chemical Tools for Studying TLR Signaling Dynamics
Timo Oosenbrug et al.
CELL CHEMICAL BIOLOGY (2017)
Constitutive resistance to viral infection in human CD141+ dendritic cells
Aymeric Silvin et al.
SCIENCE IMMUNOLOGY (2017)
Nogo-B Facilitates LPS-Mediated Immune Responses by Up-Regulation of TLR4-Signaling in Macrophage RAW264.7
Ying Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses
Subhajit Poddar et al.
JOURNAL OF VIROLOGY (2016)
The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis
Matthew J. Gorman et al.
JOURNAL OF VIROLOGY (2016)
A high-content platform to characterise human induced pluripotent stem cell lines
Andreas Leha et al.
METHODS (2016)
NOGO-A/RTN4A and NOGO-B/RTN4B are simultaneously expressed in epithelial, fibroblast and neuronal cells and maintain ER morphology
Olli Ramo et al.
SCIENTIFIC REPORTS (2016)
Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response
Dae-Gyun Ahn et al.
CELL CYCLE (2015)
Adaptor Protein-3-Mediated Trafficking of TLR2 Ligands Controls Specificity of Inflammatory Responses but Not Adaptor Complex Assembly
Tanja Petnicki-Ocwieja et al.
JOURNAL OF IMMUNOLOGY (2015)
Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses
Toshifumi Kimura et al.
JOURNAL OF IMMUNOLOGY (2015)
Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure
Anna Cantalupo et al.
NATURE MEDICINE (2015)
IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
Jingyou Yu et al.
CELL REPORTS (2015)
CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue
Gabrielle Stack et al.
PLOS PATHOGENS (2015)
Human Cytomegalovirus Exploits Interferon-Induced Transmembrane Proteins To Facilitate Morphogenesis of the Virion Assembly Compartment
Maorong Xie et al.
JOURNAL OF VIROLOGY (2015)
HCMV pUL135 Remodels the Actin Cytoskeleton to Impair Immune Recognition of Infected Cells
Richard J. Stanton et al.
CELL HOST & MICROBE (2014)
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection
Zhongfang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms
Florian Wrensch et al.
VIRUSES-BASEL (2014)
IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion
Tanay M. Desai et al.
PLOS PATHOGENS (2014)
The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry
Samad Amini-Bavil-Olyaee et al.
CELL HOST & MICROBE (2013)
Defining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model
Aaron R. Everitt et al.
PLOS ONE (2013)
TLR2 Ligands Induce NF-κB Activation from Endosomal Compartments of Human Monocytes
Karim J. Brandt et al.
PLOS ONE (2013)
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals
Yong-Hong Zhang et al.
NATURE COMMUNICATIONS (2013)
Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction
Tsai-Yu Lin et al.
CELL REPORTS (2013)
IFITM Proteins Restrict Viral Membrane Hemifusion
Kun Li et al.
PLOS PATHOGENS (2013)
Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
Matthew M. Meredith et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
IFITM3 restricts the morbidity and mortality associated with influenza
Aaron R. Everitt et al.
NATURE (2012)
Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation
Kenneth D. Harrison et al.
EMBO JOURNAL (2011)
A Multi-domain Fragment of Nogo-A Protein Is a Potent Inhibitor of Cortical Axon Regeneration via Nogo Receptor 1
Eric A. Huebner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The IFITM Proteins Inhibit HIV-1 Infection
Jennifer Lu et al.
JOURNAL OF VIROLOGY (2011)
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
I-Chueh Huang et al.
PLOS PATHOGENS (2011)
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication
Richard J. Stanton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct Mechanisms
Jessica M. Weidner et al.
JOURNAL OF VIROLOGY (2010)
Murine Toll-Like Receptor 2 Activation Induces Type I Interferon Responses from Endolysosomal Compartments
Nicole Dietrich et al.
PLOS ONE (2010)
Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
Miwa Sasai et al.
SCIENCE (2010)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands
Roman Barbalat et al.
NATURE IMMUNOLOGY (2009)
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E
Christian Sinzger et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection
Nicolas Zucchini et al.
JOURNAL OF IMMUNOLOGY (2008)
Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling; role of CD14 and CD36
Nadra J. Nilsen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta
Jonathan C. Kagan et al.
NATURE IMMUNOLOGY (2008)
PirB is a Functional Receptor for Myelin Inhibitors of Axonal Regeneration
Jasvinder K. Atwal et al.
SCIENCE (2008)
Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members
Juha Lauren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells
Karl W. Boehme et al.
JOURNAL OF IMMUNOLOGY (2006)
Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting
Martha Triantafilou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells
Robert Qing Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A class of membrane proteins shaping the tubular endoplasmic reticulum
GK Voeltz et al.
CELL (2006)
Recognition of single-stranded RNA viruses by Toll-like receptor 7
JM Lund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A new role for Nogo as a regulator of vascular remodeling
L Acevedo et al.
NATURE MEDICINE (2004)
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
K Tabeta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lipoteichoic acid and Toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent
M Triantafilou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Reticulon family members modulate BACE1 activity and amyloid-β peptide generation
WX He et al.
NATURE MEDICINE (2004)
Axon regeneration in young adult mice lacking Nogo-A/B
JE Kim et al.
NEURON (2003)
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2
T Compton et al.
JOURNAL OF VIROLOGY (2003)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration
AE Fournier et al.
NATURE (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
Share Paper
